English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

The determination of serum beta-glucuronidase (b-Dglucuronide glucuronohydrolase, EC 3.2.1.31) is of clinical interest because it can be used in the diagnosis of several pathological conditions. Serum levels of betaglucuronidase are increased in patients with such conditions as neopalms [1], diabetes mellitus [2 and 3], in pregnant women and in gestational diabetes [4], atherosclerotic disease [5], coronary artery disease [6], and Gaucher’s disease [7]. However, it is practically absent in sera of patients with mucopolisaccharidosis [8].

An automated determination of beta‐glucuronidase activity in human serum with the Abbot VP bichromatic analyzer